ImmuCell Corporation
ICCC
$6.52
$0.345.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 430.44% | 145.15% | 25.35% | -11.01% | 81.09% |
| Total Depreciation and Amortization | 1.30% | -0.16% | -3.61% | -2.02% | 1.58% |
| Total Amortization of Deferred Charges | 5.88% | 6.93% | 24.14% | 468.42% | 436.84% |
| Total Other Non-Cash Items | -56.29% | -67.86% | -75.44% | -21.69% | -61.33% |
| Change in Net Operating Assets | -528.25% | -234.83% | -50.77% | 1,709.13% | 111.09% |
| Cash from Operations | 276.06% | 99.57% | -25.90% | 185.38% | 115.15% |
| Capital Expenditure | -367.47% | -141.33% | 78.98% | 84.38% | 89.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 4,400.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -367.47% | -680.47% | 83.42% | 85.01% | 89.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.15% | -4.88% | 84.16% | -44.66% | -43.79% |
| Issuance of Common Stock | -- | 4,234.57% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -760.00% | -1,857.83% | 100.00% | -- | -- |
| Cash from Financing | -10.12% | 146.33% | 103.79% | 55.70% | -148.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,671.20% | 95.01% | 364.18% | 122.17% | 99.32% |